ScienceDaily (Mar. 20, 2008) — Thanks to early diagnosis and chemotherapy, more women survive breast cancer than ever before. However, following treatment, approximately 25 percent of survivors experience mild to moderate memory, concentration and cognitive problems known as “chemobrain”.
